J-H Fu
Overview
Explore the profile of J-H Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hou X, Yang M, Li J, Tan Z, Long H, Fu J, et al.
ESMO Open
. 2022 Jun;
7(3):100508.
PMID: 35688064
Background: The benefit of adjuvant chemotherapy (ACT) in pathological T2N0M0 non-small-cell lung cancer (NSCLC) patients is not clear. Methods: One thousand and fifty pathological T2N0M0 NSCLC patients were included and...
2.
Fu J, Yang S, Nan C, Zhou C, Lu D, Li S, et al.
Eur Rev Med Pharmacol Sci
. 2020 Jul;
24(13):7202.
PMID: 32706040
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-182 affects renal cancer...
3.
Mao Y, Gao S, Wang Q, Shi X, Li Y, Gao W, et al.
Dis Esophagus
. 2019 Dec;
33(8).
PMID: 31863099
Method: A National Database was setup through a network platform, and data was collected from 70 high-volume centers (>100 esophagectomies/per year) across China. Data was entered between January 2009 and...
4.
Fu J, Zhou C, Mu H, Nan C, Li S, Lu D
Eur Rev Med Pharmacol Sci
. 2019 Apr;
23(7):2750-2755.
PMID: 31002125
Objective: Gene mutation is closely related to the occurrence of tumor. Renal cell carcinoma is a malignant tumor, seriously threatening patients' life quality. Regulatory T cells (Treg) play important roles...
5.
Fu J, Yang S, Nan C, Zhou C, Lu D, Li S, et al.
Eur Rev Med Pharmacol Sci
. 2018 Feb;
22(2):351-357.
PMID: 29424922
Objective: PI3K/AKT/mTOR signaling pathway plays a crucial role in tumorigenesis and development. It was shown that mTOR overexpression was associated with the pathogenesis of renal cancer. Down-regulation of MiR-182 was...
6.
Li Q, Qiu B, Wang B, Wang D, Yin S, Yang H, et al.
Dis Esophagus
. 2017 Oct;
31(2).
PMID: 29036528
This study aims to investigate the role of diffusion-weighted magnetic resonance imaging (DW-MRI) in ESCC patients receiving neoadjuvant concurrent chemoradiotherapy (CCRT), and the efficacy of apparent diffusion coefficient (ADC) values...
7.
Hou X, Fu J, Wang X, Zhang L, Liu Q, Luo K, et al.
Eur J Surg Oncol
. 2014 Jun;
40(12):1756-62.
PMID: 24913091
Purpose: This study aimed to determine the impact of prophylactic thoracic duct ligation on overall survival in resectable oesophageal cancer patients. Methods: We conducted a retrospective analysis of 1804 patients...
8.
Xie X, Zhang S, Wen J, Yang H, Luo K, Yang F, et al.
Dis Esophagus
. 2013 Apr;
27(2):188-95.
PMID: 23621299
Protein kinase D1 (PRKD1) is a kinase that regulates various pathways, which involve in cell proliferation, apoptosis, cell adhesion and invasion. Although PRKD1 expression has been observed in many cancers,...
9.
Zhang S, Yang H, Xie X, Luo K, Wen J, Bella A, et al.
Dis Esophagus
. 2013 Apr;
27(6):574-84.
PMID: 23621119
The effect of adjuvant chemotherapy on survival of patients with thoracic esophageal squamous cell carcinomas is still controversial, and the subgroup of patients who will most likely benefit from the...
10.
Hou X, Li Y, Luo R, Fu J, He J, Zhang L, et al.
Eur J Surg Oncol
. 2012 Mar;
38(6):523-30.
PMID: 22440742
Purpose: To investigate the correlation between p300 (a transcriptional co-activator) expression and clinical/prognostic characteristics in surgically resected NSCLC patients for the purpose of identifying patients with increased risk of cancer...